{"DataElement":{"publicId":"2003721","version":"4","preferredName":"Common Toxicity Criteria Adverse Event Grade","preferredDefinition":"Adverse Event numeric grade (0-5) based on the NCI Common Toxicity Criteria.","longName":"CTC_AE_GD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2012749","version":"3","preferredName":"Common Toxicity Criteria Grade","preferredDefinition":"A set of terminology used to report adverse event severity (grade).","longName":"CTC_GD","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2188330","version":"1","preferredName":"Common Toxicity Criteria","preferredDefinition":"Common Toxicity Criteria; a set of terminology used to report adverse events in clinical trials.","longName":"C25468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Toxicity Criteria","conceptCode":"C25468","definition":"Common Toxicity Criteria; a set of terminology used to report adverse events in clinical trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"E3BF78C8-8F53-6255-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-10","endDate":"2011-11-18","createdBy":"REEVESD","dateCreated":"2004-09-10","modifiedBy":"TAYLORT","dateModified":"2020-10-20","changeDescription":"10.20.20 Moved from RETIRED WITHDRAWN to RETIRED ARCHIVED in preparation of MDR; TL. 11/18/2011 - tc - NCIt has retired this term; use C49704 as a replacement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177522","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5203-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A60F82D2-CBD3-3681-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-18","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Use caBIG OC ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2178456","version":"1","preferredName":"Adverse Event Common Toxicity Criteria Grade Number","preferredDefinition":"Adverse Event numeric grade (0-5) based on the NCI Common Toxicity Criteria.","longName":"AE_CTC_GD_NUM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"No adverse event or within normal limits","ValueMeaning":{"publicId":"2562273","version":"1","preferredName":"No adverse event or within normal limits","longName":"2562273","preferredDefinition":"NO ADVERSE EVENT OR WITHIN NORMAL LIMITS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40F9-47F4-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"MILD ADVERSE EVENT","ValueMeaning":{"publicId":"2575939","version":"1","preferredName":"MILD ADVERSE EVENT","longName":"2575939","preferredDefinition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Adverse Event","conceptCode":"C41338","definition":"An experience that is usually transient, and requires no special treatment or intervention. The event does not generally interfere with usual daily activities. Includes transient laboratory test alterations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40FA-47F4-E034-0003BA12F5E7","beginDate":"2002-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"MODERATE ADVERSE EVENT","ValueMeaning":{"publicId":"2575940","version":"1","preferredName":"MODERATE ADVERSE EVENT","longName":"2575940","preferredDefinition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Adverse Event","conceptCode":"C41339","definition":"An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40FB-47F4-E034-0003BA12F5E7","beginDate":"2002-04-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"SEVERE AND UNDESIRABLE ADVERSE EVENT","ValueMeaning":{"publicId":"2562275","version":"1","preferredName":"SEVERE AND UNDESIRABLE ADVERSE EVENT","longName":"2562275","preferredDefinition":"SEVERE AND UNDESIRABLE ADVERSE EVENT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C050-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40FC-47F4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","ValueMeaning":{"publicId":"2562276","version":"1","preferredName":"LIFE-THREATENING OR DISABLING ADVERSE EVENT","longName":"2562276","preferredDefinition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Life Threatening or Disabling Adverse Event","conceptCode":"C41337","definition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C051-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"CURTIST","dateModified":"2015-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40FD-47F4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"DEATH RELATED TO ADVERSE EVENT","ValueMeaning":{"publicId":"2562274","version":"1","preferredName":"DEATH RELATED TO ADVERSE EVENT","longName":"2562274","preferredDefinition":"The termination of life as a result of an adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death Related to Adverse Event","conceptCode":"C48275","definition":"The termination of life associated with an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C04F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-07","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-07","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CC812908-40FE-47F4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177868","version":"1","preferredName":"Number","preferredDefinition":"a concept of quantity derived from zero and units.","longName":"Number","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA35863A-4B1D-728A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-22","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC812908-40F5-47F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"REEVESD","dateModified":"2009-09-23","changeDescription":"Supports CTMS reporting requirements.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811686","version":"1","longName":"CTMSv3.02","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812831","version":"1","longName":"Oregon Health & Sciences University","context":"NCIP"},{"publicId":"2812832","version":"1","longName":"OHSU_288","context":"NCIP"},{"publicId":"2812586","version":"1","longName":"Lombardi 04251","context":"NCIP"},{"publicId":"2812583","version":"1","longName":"Panvec","context":"NCIP"},{"publicId":"2812577","version":"1","longName":"DFMO/Sul Colon III UCI 02_06","context":"NCIP"},{"publicId":"2811716","version":"1","longName":"UC Irvine","context":"NCIP"},{"publicId":"2812578","version":"1","longName":"UCI 0404","context":"NCIP"},{"publicId":"2812585","version":"1","longName":"Lombardi 03058","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812573","version":"1","longName":"Albert Einstein Medical Center","context":"NCIP"},{"publicId":"2812812","version":"1","longName":"AE_104_085","context":"NCIP"},{"publicId":"2812726","version":"1","longName":"U Nebraska Med Center","context":"NCIP"},{"publicId":"2812981","version":"1","longName":"UNMC 284-04","context":"NCIP"},{"publicId":"2812727","version":"1","longName":"U of Pa Cancer Center","context":"NCIP"},{"publicId":"2812574","version":"1","longName":"UPCC 07403","context":"NCIP"},{"publicId":"2812584","version":"1","longName":"Lombardi 02452","context":"NCIP"},{"publicId":"2812580","version":"1","longName":"Duke 500","context":"NCIP"},{"publicId":"2812582","version":"1","longName":"P1_CPT_BCNU_RD","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812581","version":"1","longName":"DC_0205","context":"NCIP"},{"publicId":"2812731","version":"1","longName":"U Washington","context":"NCIP"},{"publicId":"2812732","version":"1","longName":"FES Study","context":"NCIP"},{"publicId":"2812733","version":"1","longName":"FMISO Study","context":"NCIP"},{"publicId":"2813032","version":"1","longName":"Catheter Protocol","context":"NCIP"}]},{"publicId":"2857175","version":"1","longName":"C3D Adopter CDEs for Reuse","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812490","version":"1","longName":"CTMS 3.12B","context":"CCR"}]}],"AlternateNames":[{"name":"CTC_AE_GD","type":"USED_BY","context":"SPOREs"},{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"},{"name":"CTC_GRADE","type":"C3D Name","context":"CCR"},{"name":"CTC_AE_GD","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"AE Grade","type":"Preferred Question Text","description":"AE Grade","url":null,"context":"CCR"},{"name":"CRF TEXT15","type":"Alternate Question Text","description":"Common Toxicity Criteria Adverse Event Grade","url":null,"context":"NCIP"},{"name":"CCR Immunotherapy Migration","type":"Alternate Question Text","description":"Grade","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CC812908-4100-47F4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-11-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-11-19","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"CDE value domain changed from numeric to character, Preferred name revised 11/19/03.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}